India's ART (Regulation) Act and associated rules require registered ART clinics and banks to screen patients (and, where applicable, donors) for specified infections — including HIV, hepatitis B, hepatitis C, and syphilis, alongside relevant tests for STIs — before fertility treatment begins. This protects patients, any future child, and laboratory staff, and ensures results are properly documented as part of the clinic's records. Screening is a routine, expected part of starting IUI, IVF, ICSI or donor gamete treatment in a registered clinic, not a sign that anything is wrong; it applies to essentially all patients as a safeguard, and results guide (rather than block) safe treatment planning. This is general information about India's ART and surrogacy framework and is not personalised legal advice. India legal information last reviewed: 9 September 2026.
Also known as: mandatory infection testing, pre-IVF blood tests
Related India guides
Sources
- Assisted Reproductive Technology (Regulation) Act, 2021, with the ART (Regulation) Rules and subsequent amendments and notifications (indiacode.nic.in; artsurrogacy.gov.in)
- National AIDS Control Organisation, Government of India (naco.gov.in)
Last reviewed: 9 September 2026. Written by the Antega Editorial Team. General information only — always follow the advice of your own clinic, doctor or pharmacist.